# Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis

> **NCT00878774** · PHASE2 · COMPLETED · sponsor: **Circassia Limited** · enrollment: 50 (estimated)

## Conditions studied

- Allergy

## Interventions

- **BIOLOGICAL:** ToleroMune Ragweed
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00878774
- **Lead sponsor:** Circassia Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2010-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00878774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00878774, "Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00878774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*